This program is supported through an independent educational grant from MSD. It is intended for healthcare professionals globally.
In this 15-minute on-demand session, cardiovascular expert William Callahan, DO provides practical, case-based insights on identifying and stratifying patients at elevated risk for atherosclerotic cardiovascular disease (ASCVD). Drawing on the latest international guidelines and clinical trial evidence, Dr. Callahan demonstrates how to apply validated risk assessment tools, recognize underserved and high-need populations—including those with familial hypercholesterolaemia—and incorporate risk-enhancing factors into everyday practice.
Through real-world scenarios, participants will learn to move beyond short-term LDL-C targets and apply lifetime risk perspectives to guide earlier, more effective interventions for ASCVD prevention.
Accreditation: AffinityCE designates this activity for 0.25 AMA PRA Category 1 Credit™.
This concise session uses interactive case discussions and expert commentary to help clinicians strengthen their ability to identify high-risk patients and confidently stratify ASCVD risk in diverse practice settings.
Learning Highlights
- Recognize the role of cumulative LDL-C exposure as a driver of long-term ASCVD risk.
- Apply validated risk tools (e.g., SCORE2, pooled cohort equations) with risk-enhancing factors such as FH and social determinants of health.
- Stratify patients in underserved and high-need populations for earlier, more effective intervention.
- Incorporate lifetime ASCVD risk into treatment planning to reduce long-term burden.
Presented by
William Callahan, DO – Board-certified family physician and Assistant Director of the Abington Family Medicine Residency Program at Jefferson Health. A dedicated clinician and educator, Dr. Callahan combines comprehensive primary care practice with academic teaching, mentoring residents while advancing best practices in cardiovascular risk reduction and lipid management.
Continuing Education Information
This continuing education activity will be provided by AffinityCE and MedAll. Physicians will be eligible for AMA PRA Category 1 Credit™. A statement of participation is available for other healthcare professionals.
Disclosures
Dr William Callahan has no relevant financial relationships with any ineligible companies to disclose. These disclosures are made in accordance with ACCME standards to ensure transparency and objectivity in continuing education. Dr William Callahan does not intend to discuss any drug products and/or medical devices.
AffinityCE staff, MedAll staff, and all planners and reviewers have no relevant financial relationships with ineligible companies to disclose.
How to Earn Your CME Credit
In order to obtain your CME credit and receive your certificate, please join the webinar and complete the assessment at the end. You will receive a link to your certificate automatically after completing the assessment.
Other Professionals
All other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity.
Participation Costs
There is no cost to participate in this program.
ACCME Continuing Education Information
This continuing education activity will be provided by AffinityCE and MedAll. This activity will provide continuing education credit for physicians. A statement of participation is available to other attendees.
AffinityCE staff, MedAll staff, as well as planners and reviewers, have no relevant financial relationships with ineligible companies to disclose. Faculty disclosures will be declared prior to the event.
Mitigation of Relevant Financial Relationships
AffinityCE adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible companies. Relevant financial relationships were mitigated by the peer review of content by non-conflicted reviewers prior to the commencement of the program.
Activity Accreditation for Health Professions
Physicians
This activity will be planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and Medall. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.
AffinityCE designates this enduring activity a maximum of 0.25 AMA PRA Category 1 Credits™.
Physician Assistants
This activity will be planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and MedAll AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.
AffinityCE designates this enduring activity a maximum of 0.25 AMA PRA Category 1 Credits™. Physician assistants should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioners
This activity will be planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and MedAll. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.
AffinityCE designates this enduring activity a maximum of 0.25 AMA PRA Category 1 Credits™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.
Nurses & Other Professionals
All other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity.
Pharmacists
Pharmacists AffinityCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE).
CE Title: Recognizing High-Risk Patients & Stratifying ASCVD Risk
Pharmacist UAN: 0829-9999-25-185-H01-P
Activity Type: Knowledge-based
Contact Hour(s): 0.25
No cost to participate.
Participant CE records will be electronically communicated to CPE Monitor.
Pharmacist Learning Objectives
At the conclusion of this web conference, participants should be able to:
- Describe the clinical significance of cumulative LDL-C exposure and its direct relationship with ASCVD progression and outcomes.
System Requirements
Mobile device (e.g., large-format smart phone; laptop or tablet computer) or desktop computer with a video display of at least 1024 × 768 pixels at 24-bit color depth, capable of connecting to the Internet at broadband or faster speeds, with a current version Internet browser and popular document viewing software (e.g., Microsoft Office, PDF viewer, image viewer) installed. Support for streaming or downloadable audio-visual materials (e.g., streaming MP4, MP3 audio) in hardware and software may be required to view, review, or participate in portions of the program.
Participation Costs
There is no cost to participate in this program.
CME Inquiries
For all CME policy-related inquiries, please contact us at ce@affinityced.com.
Unapproved and/or off-label use disclosure
AffinityCE/MedAll requires CE faculty to disclose to the participants:
- When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not US Food and Drug Administration [FDA] approved); and
- Any limitations on the information presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion.